首页> 外国专利> METHODS FOR IDENTIFYING A PATIENT AS A CANDIDATE FOR TREATMENT WITH A LONG ACTING BETA AGONIST AND FOR PREDICTING A PATIENT'S RESPONSE TO LONG ACTING BETA 2 AGONIST THERAPY BY ANALYSING POLYMORPHS IMS IN THE BETA 2 -ADRENERGIC RECEPTOR GENE

METHODS FOR IDENTIFYING A PATIENT AS A CANDIDATE FOR TREATMENT WITH A LONG ACTING BETA AGONIST AND FOR PREDICTING A PATIENT'S RESPONSE TO LONG ACTING BETA 2 AGONIST THERAPY BY ANALYSING POLYMORPHS IMS IN THE BETA 2 -ADRENERGIC RECEPTOR GENE

机译:通过分析BETA 2-肾上腺素能受体基因中的多聚体磷酸酶(IMS)IMS来识别待测长效β受体激动剂的患者的候选方法以及预测患者对长效β2激动剂的反应的方法

摘要

The invention relates to a method for identifying a patient as a candidate for treatment with a long acting beta agonist comprises isolating a biological sample from a patient and identifying the presence or absence of at least one haplotype C in the beta2 -adrenergic receptor gene. The presence of at least one haplotype C in a patient sample indicates that patient is a good candidate for treatment. For example, the patient may have a respiratory disease, preferably an obstructive airway disease, and most preferably, COPD or asthma. The invention also related to a method for predicting an asthma patient's response to long acting beta2 agonist therapy comprising detecting polymorphisms in the beta2-adrenergic receptor gene.
机译:本发明涉及一种将患者鉴定为长效β激动剂治疗候选者的方法,该方法包括从患者体内分离生物样品并鉴定β2-肾上腺素能受体基因中是否存在至少一种单倍型C。患者样品中至少一种单倍型C的存在表明患者是治疗的良好候选者。例如,患者可能患有呼吸道疾病,优选阻塞性气道疾病,最优选COPD或哮喘。本发明还涉及预测哮喘患者对长效β2激动剂疗法的反应的方法,该方法包括检测β2-肾上腺素能受体基因中的多态性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号